Approvals/TGA/RILAST RAPIHALER budesonide / formoterol fumarate dihydrate 200/6 pressurised metered dose inhaler

Approved

STANDARD

RILAST RAPIHALER budesonide / formoterol fumarate dihydrate 200/6 pressurised metered dose inhaler

AstraZeneca Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: b261fa93f0763cb3
Product Name: RILAST RAPIHALER budesonide / formoterol fumarate dihydrate 200/6 pressurised metered dose inhaler
Artg Id: 396689
Artg Name: RILAST RAPIHALER budesonide / formoterol fumarate dihydrate 200/6 pressurised metered dose inhaler
Sponsor: AstraZeneca Pty Ltd
Company Detail Path: /organization/astrazeneca-pty-ltd
Artg Date: 2022-12-06
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/a69854faa61e770ba487718c72419eb9.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/3f953228b2df05d7b866fe49615dcc1a.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

b261fa93f0763cb3

Type

Standard